- Home
- RVMD vs HII Comparison
RVMD vs HII Comparison
Compare RVMD & HII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | HII |
|---|---|---|
| Founded | 2014 | 1886 |
| Country | United States | United States |
| Employees | N/A | 44000 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Marine Transportation |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 16.4B |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | RVMD | HII |
|---|---|---|
| Price | $102.71 | $438.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 6 |
| Target Price | $114.63 | ★ $379.50 |
| AVG Volume (30 Days) | ★ 1.7M | 548.9K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.25% |
| EPS Growth | N/A | ★ 10.24 |
| EPS | N/A | ★ 15.39 |
| Revenue | N/A | ★ $12,484,000,000.00 |
| Revenue This Year | N/A | $4.58 |
| Revenue Next Year | $552.08 | $6.30 |
| P/E Ratio | ★ N/A | $28.83 |
| Revenue Growth | N/A | ★ 8.23 |
| 52 Week Low | $29.17 | $167.70 |
| 52 Week High | $124.49 | $451.86 |
Technical Indicators
Market Signals| Indicator | RVMD | HII |
|---|---|---|
| Relative Strength Index (RSI) | 55.34 | 59.05 |
| Support Level | $92.76 | $263.18 |
| Resistance Level | $124.49 | N/A |
| Average True Range (ATR) | 3.62 | 15.98 |
| MACD | 0.22 | 0.96 |
| Stochastic Oscillator | 66.27 | 81.43 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About HII Huntington Ingalls Industries Inc.
Huntington Ingalls Industries is the largest independent military shipbuilder in the US, spun out from Northrop Grumman in 2011. It operates three segments, two of which are storied shipyards: Ingalls produces non-nuclear-powered ships including amphibious landing ships and Arleigh Burke-class destroyers, while Newport News produces nuclear-powered ships as the only producer of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia- and Columbia-class nuclear submarines. HII shares production of destroyers and nuclear submarines with General Dynamics' Bath Iron Works and Electric Boat shipyards, respectively. The company's mission technologies segment produces uncrewed sea vessels and provides a range of IT and other services to US government agencies.